CAP-T
The permanent CAP expression system for production of biopharmaceuticals is complemented by the CAP-T Technology for transient expression of proteins.
With CAP-T, customers can proceed within only two weeks from gene to milligram and gram amounts of protein for screening, assay development, target validation, drug discovery, early stage pre-clinical drug development and lead optimization.
CAP-T are based on CAP cells and incorporate all their positive features, such as:
- Fully documented cell line from ethically accepted source
- Certified Master Cell Bank (MCB)
- Standard Operating Procedures (SOPs)
- Efficient and scalable transfection using different commercial reagents
- Growth in suspension in serum-free and chemically defined medium
- Selected for highly efficient protein expression
- Authentic glycosylation
- Fast process times
- Easy-to-use in small-scale shaker flasks up to different bioreactor types
CEVEC´s CAP-T cells are the most flexible tool you can use during the journey from research & development to pre-clinical phases.
Not only do they match the highest quality and industry standards but you can also transfer everything you have learned about early testing of your recombinant protein expressed in CAP-T cells to stable expression in CAP cells.
Unlike other systems, we offer one platform for all your needs from early development up to clinical supply.
